Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Creative Medical Technology Holdings (CELZ) EBIT Margin (2017 - 2025)

Historic EBIT Margin for Creative Medical Technology Holdings (CELZ) over the last 9 years, with Q1 2025 value amounting to 55349.27%.

  • Creative Medical Technology Holdings' EBIT Margin changed N/A to 55349.27% in Q1 2025 from the same period last year, while for Sep 2025 it was 101379.43%, marking a year-over-year decrease of 501979200.0%. This contributed to the annual value of 52216.92% for FY2024, which is 102289900.0% up from last year.
  • According to the latest figures from Q1 2025, Creative Medical Technology Holdings' EBIT Margin is 55349.27%.
  • Creative Medical Technology Holdings' 5-year EBIT Margin high stood at 1855.31% for Q3 2022, and its period low was 62857.8% during Q4 2024.
  • For the 5-year period, Creative Medical Technology Holdings' EBIT Margin averaged around 25661.6%, with its median value being 20316.32% (2024).
  • Over the last 5 years, Creative Medical Technology Holdings' EBIT Margin had its largest YoY gain of 64790500bps in 2022, and its largest YoY loss of -315787100bps in 2022.
  • Quarter analysis of 5 years shows Creative Medical Technology Holdings' EBIT Margin stood at 2173.64% in 2021, then crashed by -1453bps to 33752.35% in 2022, then plummeted by -75bps to 59061.3% in 2023, then fell by -6bps to 62857.8% in 2024, then grew by 12bps to 55349.27% in 2025.
  • Its EBIT Margin was 55349.27% in Q1 2025, compared to 62857.8% in Q4 2024 and 20316.32% in Q2 2024.